Allogeneic, Xenogeneic, and Exogenic Hearts for Transplantation
The only curative therapy for end-stage heart failure is orthotopic allogeneic heart transplantation. This therapy has extended the survival of patients worldwide but is limited due to the scarcity of donor organs. Potential alternative donor sources of organs for transplantation include genetically...
Saved in:
| Main Authors: | Daniel J. Garry, Mary G. Garry, Hiromitsu Nakauchi, Hideki Masaki, David H. Sachs, Joshua I. Weiner, Daniel Reichart, Eckhard Wolf |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Houston Methodist DeBakey Heart & Vascular Center
2025-05-01
|
| Series: | Methodist DeBakey Cardiovascular Journal |
| Subjects: | |
| Online Access: | https://account.journal.houstonmethodist.org/index.php/up-j-mdbcj/article/view/1590 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
From genome editing to blastocyst complementation: A new horizon in heart transplantation?Central Message
by: Igor E. Konstantinov, MD, PhD, FRACS, et al.
Published: (2022-04-01) -
Derivation of resident macrophages and construction of tumor microenvironment in Flk-1-knockout chimeric mice produced via blastocyst complementation
by: Satoko Ishii, et al.
Published: (2025-07-01) -
Blastocyst complementation: current progress and future directions in xenogeneic organogenesis
by: Paula Barlabé, et al.
Published: (2025-06-01) -
RNA-Seq transcriptome analysis of porcine cloned and in vitro fertilized blastocysts
by: Wei-hua XU, et al.
Published: (2015-05-01) -
Current Techniques of Gene Editing in Pigs for Xenotransplantation
by: Cesare Galli
Published: (2025-05-01)